세계의 페니실린 G 나트륨 시장 : 산업 규모, 점유율, 동향, 기회, 예측 - 판매 채널별, 최종 용도별, 지역별, 경쟁별 부문(2020-2030년)
Penicillin G Sodium Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel, By End Use, By Region and Competition, 2020-2030F
상품코드:1728308
리서치사:TechSci Research
발행일:2025년 05월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 페니실린 G 나트륨 시장은 2024년에 2억 5,921만 달러로 평가되었고, 2030년에는 3억 9,733만 달러에 이를 전망이며, 예측 기간 동안 CAGR 4.80%를 보일 것으로 예측됩니다.
페니실린계 주사용 항생제인 페니실린 G 나트륨은 감수성이 높은 유기체에 의한 세균 감염증의 치료에 중요한 역할을 하고 있습니다. 그 임상 현장에서의 광범위한 용도는, 의약품 제조의 진보 및 적정 제조 규범(GMP)의 준수에 힘입어, 계속 시장 수요를 견인하고 있습니다. 제조 품질 및 규제 준수를 중시함으로써 주사용 페니실린 제제는 안전성과 유효성에 관한 국제 기준을 충족합니다.
시장 개요
예측 기간
2026-2030년
시장 규모(2024년)
2억 5,921만 달러
시장 규모(2030년)
3억 9,733만 달러
CAGR(2025-2030년)
4.80%
급성장 부문
직접
최대 시장
아시아태평양
시장은 헬스케어 지출 증가, 감염병 이환율 증가, 구명제에 대한 접근 확대에 중점을 둔 정부 주도 노력에 의해 더욱 자극되고 있습니다. 그러나 원료 가격의 변동, 발효 기반 생산 프로세스에 대한 의존, 정기적인 공급망 중단과 같은 과제가 제약이 되고 있습니다. 또한 지역에 따라서는 항생물질 내성에 대한 우려의 고조 및 처방 프로토콜의 엄격화가 특히 항균약의 과다 사용을 억제하는 대처에 있어서 사용을 억제할 가능성이 있습니다.
The Global Penicillin G Sodium Market was valued at USD 259.21 Million in 2024 and is projected to reach USD 397.33 Million by 2030, growing at a CAGR of 4.80% during the forecast period. Penicillin G Sodium, an essential injectable antibiotic in the penicillin family, plays a critical role in treating bacterial infections caused by susceptible organisms. Its widespread application in clinical settings continues to drive market demand, supported by advancements in pharmaceutical manufacturing and adherence to Good Manufacturing Practices (GMP). The emphasis on production quality and regulatory compliance ensures that injectable penicillin formulations meet international standards for safety and efficacy.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 259.21 Million
Market Size 2030
USD 397.33 Million
CAGR 2025-2030
4.80%
Fastest Growing Segment
Direct
Largest Market
Asia Pacific
The market is further stimulated by rising healthcare spending, increasing incidences of infectious diseases, and government-led initiatives focused on expanding access to life-saving medications. Nonetheless, challenges such as raw material price fluctuations, reliance on fermentation-based production processes, and periodic supply chain interruptions pose constraints. Additionally, growing concerns over antibiotic resistance and tighter prescribing protocols in some regions may temper usage, particularly in efforts to control antimicrobial overuse.
Key Market Drivers
Growth in Pharmaceutical Industry
The global pharmaceutical sector's expansion-particularly in emerging markets such as Asia-Pacific, Africa, and Latin America-is a major driver of demand for Penicillin G Sodium. The industry reached approximately USD 1.6 trillion in revenue by 2023, positioning it alongside the GDP of countries like Mexico or Australia. This robust growth reflects broader access to healthcare, improved medical infrastructure, and heightened health awareness. In these regions, governments and health providers are prioritizing low-cost, effective treatment options. Penicillin G Sodium, known for its reliability and affordability, remains a frontline therapy in combating bacterial infections and is widely included in public health procurement strategies.
Key Market Challenges
Volatility in Raw Material Prices
Price instability in key raw materials poses a significant challenge to the Penicillin G Sodium market. The fermentation-based production of this antibiotic depends on raw materials like corn steep liquor, lactose, and glucose-substances sensitive to agricultural yields, energy prices, and geopolitical disruptions. Any variation in the cost or supply of these inputs can directly impact manufacturing expenses. Manufacturers are particularly vulnerable to spikes in input prices, which either compress margins or necessitate price hikes, reducing competitiveness-especially in markets dominated by cost-sensitive generics. These fluctuations can disrupt supply continuity and affect global pricing structures for Penicillin G Sodium formulations.
Key Market Trends
Expansion of Contract Manufacturing Organizations (CMOs)
A prominent trend shaping the Penicillin G Sodium market is the growing role of Contract Manufacturing Organizations (CMOs). In 2024, CMOs and CDMOs are expected to experience a growth rate of 13.8%-second only to bioprocessing segments-highlighting their increasing importance in the pharmaceutical supply chain. These organizations provide pharmaceutical companies with cost-effective production solutions, allowing firms to reduce capital expenditures on specialized equipment and compliance infrastructure. Outsourcing to CMOs is particularly advantageous for generic drug makers aiming to maintain competitiveness in highly regulated and price-sensitive markets. The scalability, operational efficiency, and regulatory alignment offered by CMOs are driving their adoption, especially for antibiotic manufacturing.
In this report, the Global Penicillin G Sodium Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Penicillin G Sodium Market, By Sales Channel:
Direct
Indirect
Penicillin G Sodium Market, By End Use:
Bacterial Infections
Syphilis
Prophylaxis
Meningitis
Combination Therapies
Others
Penicillin G Sodium Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Penicillin G Sodium Market.
Available Customizations
Global Penicillin G Sodium Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Impact of COVID-19 on Global Penicillin G Sodium Market
5. Global Penicillin G Sodium Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Sales Channel (Direct, Indirect)
5.2.2. By End Use (Bacterial Infections, Syphilis, Prophylaxis, Meningitis, Combination Therapies, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Penicillin G Sodium Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Sales Channel
6.2.2. By End Use
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Penicillin G Sodium Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Sales Channel
6.3.1.2.2. By End Use
6.3.2. Mexico Penicillin G Sodium Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Sales Channel
6.3.2.2.2. By End Use
6.3.3. Canada Penicillin G Sodium Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Sales Channel
6.3.3.2.2. By End Use
7. Europe Penicillin G Sodium Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Sales Channel
7.2.2. By End Use
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Penicillin G Sodium Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Sales Channel
7.3.1.2.2. By End Use
7.3.2. Germany Penicillin G Sodium Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Sales Channel
7.3.2.2.2. By End Use
7.3.3. United Kingdom Penicillin G Sodium Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Sales Channel
7.3.3.2.2. By End Use
7.3.4. Italy Penicillin G Sodium Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Sales Channel
7.3.4.2.2. By End Use
7.3.5. Spain Penicillin G Sodium Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Sales Channel
7.3.5.2.2. By End Use
8. Asia Pacific Penicillin G Sodium Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Sales Channel
8.2.2. By End Use
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Penicillin G Sodium Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Sales Channel
8.3.1.2.2. By End Use
8.3.2. India Penicillin G Sodium Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Sales Channel
8.3.2.2.2. By End Use
8.3.3. South Korea Penicillin G Sodium Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Sales Channel
8.3.3.2.2. By End Use
8.3.4. Japan Penicillin G Sodium Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Sales Channel
8.3.4.2.2. By End Use
8.3.5. Australia Penicillin G Sodium Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Sales Channel
8.3.5.2.2. By End Use
9. South America Penicillin G Sodium Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Sales Channel
9.2.2. By End Use
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Penicillin G Sodium Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Sales Channel
9.3.1.2.2. By End Use
9.3.2. Argentina Penicillin G Sodium Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Sales Channel
9.3.2.2.2. By End Use
9.3.3. Colombia Penicillin G Sodium Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Sales Channel
9.3.3.2.2. By End Use
10. Middle East and Africa Penicillin G Sodium Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Sales Channel
10.2.2. By End Use
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Penicillin G Sodium Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Sales Channel
10.3.1.2.2. By End Use
10.3.2. Saudi Arabia Penicillin G Sodium Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Sales Channel
10.3.2.2.2. By End Use
10.3.3. UAE Penicillin G Sodium Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Sales Channel
10.3.3.2.2. By End Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Penicillin G Sodium Market: SWOT Analysis
